Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 30 Show results per page	View Search Criteria \| Help With Results


1.		Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				40 to 90				Pharmaceutical / Industry				AVO108943 NCT00470834

Last Modified: 12/20/2006 First Published: 2/21/2003


2.		Phase III Randomized Study of Neoadjuvant Releasing Factor Agonist Therapy and Antiandrogen Therapy With or Without Docetaxel And Estramustine in Patients With Locally Advanced Prostate Cancer or With A High Risk of Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 80				Other				FRE-FNCLCC-GETUG-12/0203 EU-20238, NCT00055731


3.		Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 79				Other				JCOG0401 C000000026, NCT00138008


4.		Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				No age specified				Other				05-8-4 NCT00243646

Last Modified: 9/17/2008 First Published: 1/25/2006


5.		Phase III Randomized Study of Androgen Suppression (AS) and Radiotherapy (RT) Versus AS and RT Followed by Docetaxel and Prednisone in Patients With Localized, High-Risk Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0521 RTOG-0521, NCT00288080


6.		External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				2003-0819 NCT00388804

First Published: 10/3/2007


7.		Phase III Randomized Study of Immediate Versus Early Salvage Radiotherapy and Short- Versus Long-Term Androgen Deprivation Therapy in Patients Who Have Undergone Local Surgery for Nonmetastatic Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Any age				Other				MRC-RADICALS-PR10 MRC-RADICALS-PR10, ISRCTN40814031, EUDRACT-2006-000205-34, EU-20767, CAN-NCIC-CTG-PR13, NCT00541047

Last Modified: 9/16/2008 First Published: 12/3/2007


8.		Phase III Randomized Study of Prostate Bed Radiotherapy (BPRT) Alone Versus Short Term Androgen Deprivation Comprising Antiandrogen and Luteinizing Hormone-Releasing Hormone Agonist Therapy and Pelvic Lymph Node Radiotherapy With Versus Without BPRT in Patients With a Rising Prostate-Specific Antigen After Radical Prostatectomy for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				RTOG-0534 RTOG 0534, RTOG-0534, NCT00567580

Last Modified: 5/20/2008 First Published: 3/31/2008


9.		Phase III Randomized Study of Androgen Suppression Therapy and Radiotherapy With Versus Without Docetaxel in Patients With High-Risk Localized Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				NCI				CAN-NCIC-PR12 PR12, NCT00651326


10.		Adjuvant Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0M0 Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 to 85				Other				4P-06-3 NCT00669162

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute